Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

June 30, 2007

Conditions
Asthma
Interventions
DRUG

Budesonide/Formoterol

Trial Locations (18)

Unknown

Research Site, Komaki

Research Site, Seto

Research Site, Gifu

Research Site, Ōwa

Research Site, Hiroshima

Research Site, Sapporo

Research Site, Tomakomai

Research Site, Morioka

Research Site, Takamatsu

Research Site, Kagoshima

Research Site, Kochi

Research Site, Beppu

Research Site, Tsukubo-gun

Research Site, Kishiwada

Research Site, Takatsuki

Research Site, Ōta-ku

Research Site, Shinjuku-ku

Research Site, Ube

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY